rs3750512

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000850853.1(TRAF2):​c.*715G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.629 in 156,638 control chromosomes in the GnomAD database, including 31,299 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.63 ( 30462 hom., cov: 34)
Exomes 𝑓: 0.59 ( 837 hom. )

Consequence

TRAF2
ENST00000850853.1 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0580

Publications

16 publications found
Variant links:
Genes affected
TRAF2 (HGNC:12032): (TNF receptor associated factor 2) The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins associate with, and mediate the signal transduction from members of the TNF receptor superfamily. This protein directly interacts with TNF receptors, and forms a heterodimeric complex with TRAF1. This protein is required for TNF-alpha-mediated activation of MAPK8/JNK and NF-kappaB. The protein complex formed by this protein and TRAF1 interacts with the inhibitor-of-apoptosis proteins (IAPs), and functions as a mediator of the anti-apoptotic signals from TNF receptors. The interaction of this protein with TRADD, a TNF receptor associated apoptotic signal transducer, ensures the recruitment of IAPs for the direct inhibition of caspase activation. BIRC2/c-IAP1, an apoptosis inhibitor possessing ubiquitin ligase activity, can unbiquitinate and induce the degradation of this protein, and thus potentiate TNF-induced apoptosis. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of only one transcript has been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.828 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000850853.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF2
NM_021138.4
MANE Select
c.*715G>A
downstream_gene
N/ANP_066961.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF2
ENST00000850853.1
c.*715G>A
3_prime_UTR
Exon 11 of 11ENSP00000520942.1
TRAF2
ENST00000882552.1
c.*715G>A
3_prime_UTR
Exon 12 of 12ENSP00000552611.1
TRAF2
ENST00000882555.1
c.*715G>A
3_prime_UTR
Exon 11 of 11ENSP00000552614.1

Frequencies

GnomAD3 genomes
AF:
0.630
AC:
95790
AN:
152074
Hom.:
30448
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.624
Gnomad AMI
AF:
0.641
Gnomad AMR
AF:
0.537
Gnomad ASJ
AF:
0.671
Gnomad EAS
AF:
0.849
Gnomad SAS
AF:
0.749
Gnomad FIN
AF:
0.658
Gnomad MID
AF:
0.623
Gnomad NFE
AF:
0.622
Gnomad OTH
AF:
0.636
GnomAD4 exome
AF:
0.591
AC:
2628
AN:
4446
Hom.:
837
Cov.:
0
AF XY:
0.597
AC XY:
1362
AN XY:
2282
show subpopulations
African (AFR)
AF:
0.846
AC:
22
AN:
26
American (AMR)
AF:
0.489
AC:
639
AN:
1308
Ashkenazi Jewish (ASJ)
AF:
0.583
AC:
7
AN:
12
East Asian (EAS)
AF:
0.730
AC:
143
AN:
196
South Asian (SAS)
AF:
0.743
AC:
226
AN:
304
European-Finnish (FIN)
AF:
0.571
AC:
8
AN:
14
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
0.611
AC:
1463
AN:
2394
Other (OTH)
AF:
0.632
AC:
120
AN:
190
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
47
94
142
189
236
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.630
AC:
95857
AN:
152192
Hom.:
30462
Cov.:
34
AF XY:
0.634
AC XY:
47181
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.623
AC:
25886
AN:
41528
American (AMR)
AF:
0.538
AC:
8219
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.671
AC:
2330
AN:
3472
East Asian (EAS)
AF:
0.849
AC:
4392
AN:
5174
South Asian (SAS)
AF:
0.749
AC:
3617
AN:
4832
European-Finnish (FIN)
AF:
0.658
AC:
6975
AN:
10602
Middle Eastern (MID)
AF:
0.626
AC:
184
AN:
294
European-Non Finnish (NFE)
AF:
0.622
AC:
42313
AN:
67976
Other (OTH)
AF:
0.641
AC:
1356
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1876
3752
5628
7504
9380
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
798
1596
2394
3192
3990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.622
Hom.:
93068
Bravo
AF:
0.616
Asia WGS
AF:
0.766
AC:
2661
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
4.7
DANN
Benign
0.62
PhyloP100
-0.058

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3750512; hg19: chr9-139821068; API